EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic and transcriptional activities underlie stationary-phase Pseudomonas aeruginosa sensitivity to Levofloxacin

Patricia J Hare iD, Juliet R Gonzalez, Ryan M Quelle, Yi I Wu, Wendy W K Mok iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.03567-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Patricia J Hare und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology & Biophysics, UConn Health , Farmington, Connecticut, USA. Hauptthemen laut MEDLINE: Levofloxacin, Pseudomonas Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIDCR NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ubiquitous opportunistic pathogen Pseudomonas aeruginosa is highly adaptive and refractory to several different classes of antibiotics. However, we found in this study that stationary-phase P. aeruginosa cultures exhibit greater sensitivity to the fluoroquinolone Levofloxacin (Levo) than other bactericidal antibiotics, including an aminoglycoside (Tobramycin) and β-lactam (Aztreonam). To understand the basis of this sensitivity, we conducted time-lapse fluorescence microscopy experiments of cells during Levo treatment. We discovered that stationary-phase P. aeruginosa cells die rapidly during treatment and undergo heterogeneous morphological changes, including explosive lysis, filamentation, and gradual loss of membrane integrity as evidenced by propidium iodide uptake. These morphologies are reminiscent of how the model organism Escherichia coli appears when recovering from fluoroquinolone treatment, a period when activation of the DNA damage-induced SOS response is crucial. Accordingly, we monitored the morphologies and survival of P. aeruginosa Δ recA mutants and found that the SOS response is not involved in P. aeruginosa Levo sensitivity like it is for E. coli . We hypothesized that Levo sensitivity may be due to P. aeruginosa maintaining active metabolism in stationary phase. We determined that stationary-phase P. aeruginosa cells transcribe, maintain reductase activity, and accumulate reactive metabolic species which contribute to Levo-mediated death. By elucidating how P. aeruginosa cells sustain metabolic activity during the stationary phase, we can design strategies to sensitize these persistent subpopulations to Levo and maintain the efficacy of this clinically important fluoroquinolone antibiotic. IMPORTANCE The bacterial pathogen Pseudomonas aeruginosa is responsible for a variety of chronic human infections. Even in the absence of identifiable resistance mutations, this pathogen can tolerate lethal antibiotic doses through phenotypic strategies like biofilm formation and metabolic quiescence. In this study, we determined that P. aeruginosa maintains greater metabolic activity in the stationary phase compared to the model organism, Escherichia coli , which has traditionally been used to study fluoroquinolone antibiotic tolerance. We demonstrate that hallmarks of E. coli fluoroquinolone tolerance are not conserved in P. aeruginosa , including the timing of cell death and necessity of the SOS DNA damage response for survival. The heightened sensitivity of stationary-phase P. aeruginosa to fluoroquinolones is attributed to maintained transcriptional and reductase activity. Our data suggest that perturbations that suppress transcription and respiration in P. aeruginosa may actually protect the pathogen against this important class of antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevofloxacinPseudomonas InfectionsHumansPseudomonas aeruginosaEscherichia coliAnti-Bacterial AgentsFluoroquinolonesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Pseudomonas aeruginosaantibiotic tolerancefluoroquinolonestationary phasetranscription

Substanzen

LevofloxacinAnti-Bacterial AgentsFluoroquinolones

Autor:innen und Institutionen

  • Department of Molecular Biology & Biophysics, UConn Health , Farmington, Connecticut, USA.
  • School of Dental Medicine, UConn Health , Farmington, Connecticut, USA.
  • Richard D. Berlin Center for Cell Analysis and Modeling, UConn Health , Farmington, Connecticut, USA.

ORCID-Profile: Patricia J Hare, Wendy W K Mok

Förderung

  • NIGMS NIH HHS
  • NIDCR NIH HHS
  • HHS | National Institutes of Health
  • HHS | NIH | National Institute of Dental and Craniofacial Research

Zitieren

APA

Hare, P. J., Gonzalez, J. R., Quelle, R. M., Wu, Y. I., & Mok, W. W. K. (2024). Metabolic and transcriptional activities underlie stationary-phase Pseudomonas aeruginosa sensitivity to Levofloxacin. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03567-23

Vancouver

Hare PJ, Gonzalez JR, Quelle RM, Wu YI, Mok WWK. Metabolic and transcriptional activities underlie stationary-phase Pseudomonas aeruginosa sensitivity to Levofloxacin. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03567-23

BibTeX
@article{Hare2024,
  author = {Hare, Patricia J and Gonzalez, Juliet R and Quelle, Ryan M and Wu, Yi I and Mok, Wendy W K},
  title = {Metabolic and transcriptional activities underlie stationary-phase Pseudomonas aeruginosa sensitivity to Levofloxacin},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.03567-23}
}
Kostenlos starten →